FBLG · FibroBiologics Inc
United States · RS rating 32 · As of 2026-11-03
| Price | 0.99 USD |
|---|---|
| 1-day change | +7.6% |
| RS rating (overall / 1M / 3M / 12M) | 32 / 26 / 85 / 6 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 31 / 17 / 55 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +50.4% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +88.6% |
| Market cap (USD) | $6.9M |